MKI67 and neoplasm: IHC analysis showed a decreased number of ki67-positive cells in shSLC7A9-and erastin-treated tumours than in control tumours, and ki67-positive cells were fewest in shSLC7A9 + erastin–treated tumours (Fig. 7g).